Mandatum Life Insurance Company’s Gilead Sciences GILD Stock Holding History

Mandatum Life Insurance Company’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-63,793	Closed	-$4.46M	–	93
2021 Q3	$4.46M	Hold	63,793	–	–	0.83%	43
2021 Q2	$4.39M	Hold	63,793	–	–	0.8%	43
2021 Q1	$4.12M	Sell	63,793 -139	-0.2%	-$8.96K	0.82%	43
2020 Q4	$3.73M	Sell	63,932 -190	-0.3%	-$11.5K	0.78%	44
2020 Q3	$4.05M	Hold	64,122	–	–	0.89%	36
2020 Q2	$4.93M	Buy	64,122 +190	+0.3%	+$14.6K	1.18%	29
2020 Q1	$4.78M	Sell	63,932 -71	-0.1%	-$4.91K	1.28%	17
2019 Q4	$4.16M	Hold	64,003	–	–	0.87%	29
2019 Q3	$4.06M	Buy	64,003 +21,537	+51%	+$1.41M	0.81%	31
2019 Q2	$2.87M	Hold	42,466	–	–	0.6%	44
2019 Q1	$2.76M	Hold	42,466	–	–	0.6%	44
2018 Q4	$2.66M	Hold	42,466	–	–	0.63%	43
2018 Q3	$3.28M	Hold	42,466	–	–	0.62%	42
2018 Q2	$3.01M	Hold	42,466	–	–	0.58%	42
2018 Q1	$3.2M	Hold	42,466	–	–	0.59%	39
2017 Q4	$3.04M	Hold	42,466	–	–	0.47%	45
2017 Q3	$3.44M	Hold	42,466	–	–	0.46%	33
2017 Q2	$3.01M	Hold	42,466	–	–	0.41%	41
2017 Q1	$2.88M	Sell	42,466 -200	-0.5%	-$14.1K	0.38%	54
2016 Q4	$3.06M	Buy	42,666 +15,415	+57%	+$1.15M	0.42%	43
2016 Q3	$2.16M	Sell	27,251 -583	-2%	-$47.4K	0.28%	61
2016 Q2	$2.32M	Sell	27,834 -200	-0.7%	-$17.7K	0.32%	54
2016 Q1	$2.58M	Sell	28,034 -80	-0.3%	-$7.21K	0.35%	47
2015 Q4	$2.85M	Buy	+28,114	New	+$2.93M	0.39%	33

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mandatum Life Insurance Company's GILD Position: Q4 2021 in Review

Mandatum Life Insurance Company sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 63,793 shares — an estimated $4.46M sold.

Mandatum Life Insurance Company first reported a position in GILD in Q4 2015 and held it in 24 quarters. The position peaked at $4.93M in Q2 2020. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

Mandatum Life Insurance Company reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
Mandatum Life Insurance Company sold 63,793 Gilead Sciences shares in Q4 2021, an estimated $4.46M.
Mandatum Life Insurance Company first reported a position in Gilead Sciences in Q4 2015 and held it in 24 quarters.
Mandatum Life Insurance Company's Gilead Sciences position peaked at $4.93M in Q2 2020.
1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Mandatum Life Insurance Company's 13F filing for Q4 2021, filed 9 Feb 2022.